Gilead Sciences
GILD
#134
Rank
A$233.91 B
Marketcap
A$188.40
Share price
1.80%
Change (1 day)
11.48%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): A$16.03 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are A$29.73 Billion. In 2025 the company made an earning of A$13.85 Billion, an increase over its 2024 earnings that were of A$0.97 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$16.03 B15.7%
2025 A$13.85 B1319.86%
2024 A$0.97 B-89.94%
2023 A$9.70 B17.97%
2022 A$8.22 B-29.77%
2021 A$11.70 B395.99%
2020 A$2.36 B-67.66%
2019 A$7.29 B-33.84%
2018 A$11.03 B-42.35%
2017 A$19.13 B-20.87%
2016 A$24.18 B-21.06%
2015 A$30.63 B45.8%
2014 A$21.01 B253.01%
2013 A$5.95 B16.51%
2012 A$5.10 B-1.07%
2011 A$5.16 B-6.71%
2010 A$5.53 B11.75%
2009 A$4.95 B29.5%
2008 A$3.82 B19.11%
2007 A$3.21 B-455.74%
2006 -A$0.91 Billion-154.93%
2005 A$1.64 B76.99%
2004 A$0.92 B-266.16%
2003 -A$0.56 Billion-638.24%
2002 A$0.10 B31.5%
2001 A$78.94 M-242.15%
2000 -A$55.54 Million-40.2%
1999 -A$92.87 Million31.85%
1998 -A$70.44 Million8.73%
1997 -A$64.78 Million27.22%
1996 -A$50.92 Million
1994 -A$48.52 Million26.57%
1993 -A$38.33 Million46.49%
1992 -A$26.17 Million362.5%
1991 -A$5.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.74 B 142.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.97 B-1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$8.45 B-44.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.02 B 190.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.85 B-15.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.29 B-84.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.64 B-89.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$7.15 B-52.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.60 B 22.60%๐Ÿ‡บ๐Ÿ‡ธ USA